IL6 and COVID-19: Our results showed that significant decreases in the counts of lymphocytes, especially CD4+ T cell, CD8+ T cell and B cell, and an increase in IL-6 levels are typically characterized by the severity of COVID-19 patients, indicating the dysregulated inflammation and antiviral immune responses may attribute to the development of SARS-COV-2 infection.